Reviva Pharmaceuticals
2 clinical trials · Sponsor
◉ Watch Reviva Pharmaceuticals
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia (NCT05184335) | Reviva Pharmaceuticals | 2022-01-24 |
Track Reviva Pharmaceuticals automatically
Every clearance here is in the API, with alerts when new ones post.